Recombinant Human ADAMTS-L2 His-tag Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10950-AD

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10950-AD-020
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

CHO

Accession #

Q86TH1.1

Conjugate

Unconjugated

Applications

Bioactivity

View all ADAMTSL2 Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human ADAMTSL2 protein
Asp23-Ser951 with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Asp23

Predicted Molecular Mass

103 kDa

SDS-PAGE

130-144 kDa, under reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human ADAMTSL2 His-tag (Catalog# 10950-AD) immobilized at 2.00 μg/mL, 100 μL/well, the concentration of Recombinant Human Lysyl Oxidase Homolog 2 Protein (Catalog # 2639-AO) that produces 50% of the optimal binding response is approximately 0.60-3.00 μg/mL.

Scientific Data Images for Recombinant Human ADAMTS-L2 His-tag Protein, CF

Recombinant Human ADAMTS-L2 His-tag Protein Binding Activity.

When Recombinant Human ADAMTSL2 His-tag (Catalog# 10950-AD) is immobilized at 2.00 μg/mL, 100 μL/well, the concentration of Recombinant Human Lysyl Oxidase Homolog 2 Protein (2639-AO) that produces 50% of the optimal binding response is approximately 0.60-3.00 μg/mL.

Recombinant Human ADAMTS-L2 His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human ADAMTS-L2 His-tag Protein (Catalog # 10950-AD) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 130-144 kDa.

Formulation, Preparation and Storage

10950-AD
Formulation Lyophilized from a 0.2 μm filtered solution in HEPES and NaCl with Trehalose.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: ADAMTSL2

ADAMTSL2 (a disintegrin and metalloproteinase with thrombospondin motifs like 2), is one protein from a seven-member family of ADAMTS-like secreted proteins that are related to ADAMTS zinc metalloproteases but do not contain a metalloprotease domain. ADAMTSL2 contains a multidomain structure that includes an N-terminal signal sequence, C-terminal thrombospondin repeats, ADAMTS cysteine-rich and spacer modules, a PLAC domain and an N-glycan rich module unique amongst ADAMTSL family members (1). These domains play a substantial role in ADAMTS specificity and ADAMTSLs are also expected to have specific extracellular ligands. ADAMTSL2 is abundantly expressed in liver, lung, and spleen and resides in the extracellular matrix (ECM) (2). It has been shown to interact with many ECM proteins including fibrillin microfibrils (3), members of the lysyl oxidase family such as LOXL2 (4), and latent transforming growth factor beta binding protein 1 (LTBP1) (5). The interaction between ADAMTSL2 and LTBP1 and fibrillin indicates ADAMTSL2 may have a role in modulation of microfibrillar formation and function (3,5) and ADAMTSL2 has been found upregulated in cardiac fibrosis (6). Through its interaction with the LTBP1 protein and lysyl oxidase family members, ADAMTSL2 protein has been suggested to regulate the availability of TGF-beta and consequent TGF-beta signaling (1,5). Several mutations of ADAMTSL2 lead to a heterogeneous autosomal recessive disease, Geleophysic dysplasia 1 (7, 8). Geleophysic dysplasia 1 may be specifically caused by impaired secretion of ADAMTSL2 due to glycosylation differences (9). A variant of ADAMTSL2 has also been shown to result in an autosomal dominant inherited connective tissue disorder consistent with Ehlers-Danlos syndrome (10).

References

  1. Mead, T.J. and S.S. Apte. (2018) Matrix Biol. 71:225.
  2. Koo, B. et al. (2007) Matrix Biol. 26:431.
  3. Hubmacher, D. and S. S. Apte. (2015) Matrix Biol. 47:34.
  4. Aviram, R. et al. (2019) Matrix Biol. 75-76:114-125.
  5. Le Goff, C. et al. (2008) Nat. Genet. 9:1119-23.
  6. Trenson, S. et al. (2021) Circ. Heart Fail. 14:e006979.
  7. Allali, S. et al. (2011) J. Med. Genet. 48:417.
  8. Marzin, P. et al. (2009) Gene Reviews. Internet:1993-2020.
  9. Zhang, A. et al. (2020) J. Biol. Chem. 295:15742.  
  10. Steinle, J. et al. (2021) Am. J. Med. Genet. A. 185:743.

Long Name

ADAMTS-like Protein 2

Alternate Names

ADAMTSL2 ADAMTS-like 2, GPHYSD1

Entrez Gene IDs

9719 (Human)

Gene Symbol

ADAMTSL2

UniProt

Q86TH1.1

Additional ADAMTSL2 Products

Product Documents for Recombinant Human ADAMTS-L2 His-tag Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human ADAMTS-L2 His-tag Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.